Strong Q1 Results and Strategic Expansion Moves: Syngene’s Double Delight
Syngene International Limited has kick-started the fiscal year on a triumphant note. The healthcare heavyweight announced a 26% YoY increase...
Syngene International Limited has kick-started the fiscal year on a triumphant note. The healthcare heavyweight announced a 26% YoY increase...
Syngene today announced the acquisition of Unit 3 biologics manufacturing facility in Bangalore, India, from Stelis Biopharma Limited (SBL). The...